QQ客服 官方微博 反馈留言

	Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach
	Zhang, Zhichao; Song, Ting; Li, Xiangqian; Wu, Zhiyong; Feng, Yingang; Xie, Feibo; Liu, Chengwu; Qin, Jianquan; Chen, Hongbo
刊名	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
	2013
卷号	59页码:141-149
关键词	Mcl-1 Small molecule inhibitor Fragment-based approach Anticancer
ISSN号	0223-5234
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4537675
专题	大连理工大学
作者单位	1.Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China. 2.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China. 3.Dalian Univ Technol, Sch Life Sci & Technol, Dalian 116024, Peoples R China. 4.Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao 266101, Peoples R China. 5.Dalian Univ Technol, Sch Life Sci & Technol, Dalian 116024, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Zhichao,Song, Ting,Li, Xiangqian,et al. Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2013,59:141-149.
APA	Zhang, Zhichao.,Song, Ting.,Li, Xiangqian.,Wu, Zhiyong.,Feng, Yingang.,...&Chen, Hongbo.(2013).Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,59,141-149.
MLA	Zhang, Zhichao,et al."Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 59(2013):141-149.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。